Analysts EPS Estimates

Jefferies Group Increases Avago Technologies EPS Estimates (AVGO)

Jefferies Group Increases Avago Technologies EPS Estimates (AVGO)

Investment analysts at Jefferies Group hoisted their earnings per share (EPS) estimates on shares of Avago Technologies (NASDAQ:AVGO) in a note issued to investors on Thursday. The firm currently has a “hold” rating and a $104.00 price target on the company’s shares. They previously had a $84.00 price target on the stock. Jefferies Group’s price […]
Best Buy Co EPS Estimates Raised by Analysts at Piper Jaffray (BBY)

Best Buy Co EPS Estimates Raised by Analysts at Piper Jaffray (BBY)

Equities research analysts at Piper Jaffray increased their earnings per share estimates on shares of Best Buy Co (NYSE:BBY) in a research note issued to investors on Friday. The firm currently has a “buy” rating on the company’s shares. A number of other firms have also recently commented on BBY. Analysts at Telsey Advisory Group […]
Rocket Fuel EPS Estimates Cut by Needham & Company LLC (FUEL)

Rocket Fuel EPS Estimates Cut by Needham & Company LLC (FUEL)

Needham & Company LLC reduced their EPS estimates on shares of Rocket Fuel (NASDAQ:FUEL) in a research note issued on Thursday. The firm currently has a “buy” rating and a $25.00 target price on the company’s shares. They previously had a $30.00 target price on the stock. Needham & Company LLC’s price target points to […]
Web.com Group Earnings Estimates Trimmed at RBC Capital (WWWW)

Web.com Group Earnings Estimates Trimmed at RBC Capital (WWWW)

Equities research analysts at RBC Capital dropped their earnings per share (EPS) estimates on shares of Web.com Group (NASDAQ:WWWW) in a research note issued to investors on Thursday. The firm currently has an “in-line” rating on the company’s shares. In other Web.com Group news, EVP Roseann Duran sold 20,000 shares of the stock on the […]
Myriad Genetics Earnings Estimates Trimmed at Jefferies Group (MYGN)

Myriad Genetics Earnings Estimates Trimmed at Jefferies Group (MYGN)

Research analysts at Jefferies Group decreased their earnings per share estimates on shares of Myriad Genetics (NASDAQ:MYGN) in a report released on Wednesday. The firm currently has a “hold” rating on the company’s shares. A number of other firms have also recently commented on MYGN. Analysts at Zacks reiterated a “neutral” rating on shares of […]
Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.